| scholarly article | Q13442814 |
| P50 | author | Colin L. Masters | Q1108510 |
| Roberto Cappai | Q42174255 | ||
| Catriona A. McLean | Q68267862 | ||
| P2093 | author name string | Victor L Villemagne | |
| Christopher C Rowe | |||
| Qiao-Xin Li | |||
| Laura Leone | |||
| Michelle T Fodero-Tavoletti | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 198-204 | |
| P577 | publication date | 2009-01-21 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Characterization of PiB binding to white matter in Alzheimer disease and other dementias | |
| P478 | volume | 50 |
| Q57982373 | 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease |
| Q27499311 | 18F-florbetaben Aβ imaging in mild cognitive impairment |
| Q42945648 | 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial |
| Q30971403 | 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception |
| Q33747987 | Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers |
| Q43161462 | Amyloid PET imaging: applications beyond Alzheimer's disease |
| Q26750249 | Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging |
| Q24648007 | Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo |
| Q33856185 | Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury |
| Q48830480 | Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies? |
| Q37086266 | Amyloid-β positron emission tomography imaging probes: a critical review |
| Q43058539 | Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease |
| Q48299792 | Binding of 11C-Pittsburgh compound-B correlated with white matter injury in hypertensive small vessel disease. |
| Q34102331 | Brain imaging in the study of Alzheimer's disease |
| Q46067045 | Centiloid method evaluation for amyloid PET of subcortical vascular dementia |
| Q27003078 | Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias |
| Q42108768 | Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease |
| Q46176733 | Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole. |
| Q88646616 | Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation |
| Q38333029 | Imaging of β-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience |
| Q38600277 | Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis |
| Q36748573 | In Vivo Amyloid-β Imaging in the APPPS1-21 Transgenic Mouse Model with a (89)Zr-Labeled Monoclonal Antibody |
| Q31059488 | In Vivo Imaging of Human Neuroinflammation |
| Q33601277 | In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia |
| Q33703186 | Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain |
| Q37402288 | Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects. |
| Q53042095 | Investigation of (11)C-PiB equivocal PET findings. |
| Q64070285 | Investigation of white matter PiB uptake as a marker of white matter integrity |
| Q36745084 | Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans |
| Q37530392 | Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model |
| Q24618963 | MR-less surface-based amyloid assessment based on 11C PiB PET |
| Q38210272 | PET imaging in multiple sclerosis |
| Q87239143 | PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB |
| Q38406166 | Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis |
| Q53025487 | Preclinical Comparison of the Amyloid-β Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis. |
| Q42365124 | Rats Remember Items in Context Using Episodic Memory |
| Q35557099 | Reduced retention of Pittsburgh compound B in white matter lesions |
| Q36205167 | Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysis |
| Q92136811 | Spill-in counts in the quantification of 18F-florbetapir on Aβ-negative subjects: the effect of including white matter in the reference region |
| Q36526176 | Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta |
| Q37722942 | Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of β-Amyloid Images |
| Q37346940 | Washout allometric reference method (WARM) for parametric analysis of [(11)C]PIB in human brains |
| Q88413710 | White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition |
Search more.